Fulgent Genetics (FLGT) Depreciation & Amortization (CF) (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Depreciation & Amortization (CF) data on file, last reported at $6.0 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 1.37% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.1 million (down 0.81% YoY) and the FY2025 annual result came in at $24.1 million, down 3.23% from the prior year.
• Depreciation & Amortization (CF) slipped to $6.0 million in Q1 2026 per FLGT's latest filing, from $6.1 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $9.8 million in Q3 2022, with the low at $110000.0 in Q3 2025.
• Average Depreciation & Amortization (CF) over 5 years is $6.0 million, with a median of $6.2 million recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) soared 245.12% in 2022 and slumped 97.37% in 2024.
• Fulgent Genetics' Depreciation & Amortization (CF) stood at $9.8 million in 2022, then plunged by 33.35% to $6.5 million in 2023, then slipped by 5.22% to $6.2 million in 2024, then declined by 1.29% to $6.1 million in 2025, then fell by 1.83% to $6.0 million in 2026.
• Business Quant data shows FLGT's Depreciation & Amortization (CF) at $6.0 million in Q1 2026, $6.1 million in Q4 2025, and $110000.0 in Q3 2025.